PhRMA jumps into Integrilin off-label case, free-speech arguments at the ready

Tracy Staton Since a U.S. circuit court decided the First Amendment protected a pharma sales rep from off-label marketing charges, the free-speech arguments have multiplied in cases ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS